Ajanta Pharma Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Ajanta Pharma stock has a consensus rating of "Strong Buy" and an average price target of ₹3,303. The average 1-year stock price forecast is 12.70% higher than the current stock price, while the lowest is ₹2,605 (-11.12%) and the highest is ₹3,829 (+30.64%).

Price Target: ₹3,303 (+12.70%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	₹2,605	₹3,303	₹3,363	₹3,829
Change	-11.12%	+12.70%	+14.72%	+30.64%

* Price targets were last updated on Feb 1, 2026.

Analyst Ratings

The average analyst rating for Ajanta Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Apr '26	May '26
Strong Buy	9	9	9	9	9	11
Buy	1	1	1	1	1	1
Hold	1	1	0	0	0	0
Sell	2	2	2	2	2	1
Strong Sell	0	0	0	0	0	0
Total	13	13	12	12	12	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst ICICI Securities No rating	ICICI Securities	Buy Maintains ₹3,270	Buy	Maintains	₹3,270	+11.57%	Feb 1, 2026
Unknown Analyst Motilal Oswal No rating	Motilal Oswal	Buy Maintains ₹3,145	Buy	Maintains	₹3,145	+7.30%	Dec 29, 2025

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.